All in the Family: Raising Awareness and Support for GBM Research
Join us July 19 to raise $50K for GBM research.
GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Join us July 19 to raise $50K for GBM research.
Discover how you can play a role in the ABTA’s five-year campaign “Meet Hope Head On.”
Join us in our mission to accelerate research breakthroughs and fuel hope for brain tumor patients and families.
Discover how we’re closer to tripling our investment in research thanks to your support of Meet Hope Head On!
In his own words, caregiver and musician Scott Ingersoll shares how he used music to channel his wife’s journey battling astrocytoma.
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
Discover how one couple’s efforts to make a difference after their young son was diagnosed with a brain tumor led to their vital role in establishing the ABTA and ensuring its ongoing success.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
A first-in-class targeted therapy for low-grade glioma could gain FDA approval as early as spring 2024. Here are three things you should know about the emerging drug “vorasidenib.”
Always free for patients & caregivers
Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor
Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.
